Zhichen Sun
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 5
- Immunology 15
- Immunotherapy and Immune Responses 11
- T-cell and B-cell Immunology 5
- Co-authors
- Yang‐Xin Fu (18 shared papers)Zhida Liu (4 shared papers)Hua Peng (11 shared papers)Jinming Gao (5 shared papers)Baran D. Sumer (4 shared papers)Jonathan Wilhelm (3 shared papers)Suxin Li (3 shared papers)Yong Liang (8 shared papers)
- Journals
- Nature Communications (5 papers)Scientific Reports (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Advanced Science (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhichen Sun
29 papers receiving 1.8k citations
Zhichen Sun's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 783
- Immunology 616
- Cancer Research 244
- Biomaterials 123
- Epidemiology 176
Countries citing papers authored by Zhichen Sun
This map shows the geographic impact of Zhichen Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichen Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichen Sun more than expected).
Fields of papers citing papers by Zhichen Sun
This network shows the impact of papers produced by Zhichen Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichen Sun. The network helps show where Zhichen Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhichen Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity Hit paper breakdown → | 2022 | 321 |
| 2 | 2019 | 193 | |
| 3 | 2019 | 171 | |
| 4 | 2021 | 104 | |
| 5 | STING licensing of type I dendritic cells potentiates antitumor immunity Hit paper breakdown → | 2024 | 96 |
| 6 | 2020 | 95 | |
| 7 | 2020 | 89 | |
| 8 | 2018 | 79 | |
| 9 | 2016 | 77 | |
| 10 | 2021 | 74 | |
| 11 | 2011 | 66 | |
| 12 | 2022 | 62 | |
| 13 | 2020 | 54 | |
| 14 | 2017 | 49 | |
| 15 | Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity | 2022 | 48 |
| 16 | 2016 | 39 | |
| 17 | 2020 | 30 | |
| 18 | 2017 | 29 | |
| 19 | 2022 | 24 | |
| 20 | 2018 | 22 |
About Zhichen Sun
Zhichen Sun is a scholar working on Oncology, Immunology, Biomaterials, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (5 papers), Hepatitis B Virus Studies (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer, Hypoxia, and Metabolism (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (783 citations), Immunology (616 citations), Cancer Research (244 citations), Biomaterials (123 citations) and Epidemiology (176 citations). Zhichen Sun has collaborated with scholars based in China and United States. Frequent co-authors include Yang‐Xin Fu, Zhida Liu, Hua Peng, Jinming Gao, Baran D. Sumer, Jonathan Wilhelm, Suxin Li, Yong Liang, Zhenhua Ren and Tongyi Huang. Their work appears in journals such as Nature Communications, Scientific Reports, Journal for ImmunoTherapy of Cancer, Advanced Science and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.